BioPharma Dive October 2, 2023
Mark Lambrecht, Senior Director, Health and Life Sciences Practice

When we start to talk about the use of open source technologies in life sciences, leaders fall into two main groups of thought: either we’re going all in on open source, or we’ll never compliantly be able to.

For the former, diving in to open source is exciting in the pursuit of building a more efficient life sciences ecosystem. From molecule discovery to trial enrollment and every step in between, the idea of using open source for innovation, increased speed and improved drug delivery is top of mind for many research teams.

At the same time, the latter group of thinking is still present: in order to maintain regulatory compliance, open source seems like a nonstarter. How could we include...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Biotechnology, Pharma / Biotech, Technology
STAT+: First recipient of kidney transplant from genetically engineered pig has died, family says
Long COVID and your brain: the effect of virus and vaccines
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
Sanofi pays $1.2B to partner with Novavax on COVID-19 vaccine
1 in 8 adults has taken Ozempic or other GLP-1 drug: Survey

Share This Article